AI Engines For more Details: Perplexity Kagi Labs You
Antioxidant Properties: Humic substances contain antioxidant compounds that may help neutralize harmful free radicals in the body, reducing oxidative stress and inflammation. By scavenging free radicals, humic substances may offer protective effects against various chronic diseases associated with oxidative damage, such as cardiovascular disease, neurodegenerative disorders, and certain types of cancer.
Immune Modulation: Some studies suggest that humic substances may possess immunomodulatory properties, meaning they can modulate the activity of the immune system. By regulating immune responses, humic substances may help support immune function and enhance the body's ability to defend against infections, allergies, and autoimmune disorders. However, further research is needed to fully understand the mechanisms underlying these effects and their clinical significance.
Gastrointestinal Health: Humic substances have been investigated for their potential benefits in promoting gastrointestinal health. It is proposed that humic substances may support digestive function, enhance nutrient absorption, and maintain gut microbiota balance. Additionally, some studies suggest that humic substances may have prebiotic properties, stimulating the growth of beneficial bacteria in the gut and contributing to overall gut health.
Detoxification: Humic substances have been proposed to have detoxifying properties, assisting the body in removing toxins, heavy metals, and other harmful substances. By binding to toxins and facilitating their excretion, humic substances may help protect against toxic overload and reduce the risk of toxin-related health conditions. However, more research is needed to evaluate the efficacy of humic substances as detoxifying agents and their potential clinical applications.
Skin Health: Topical applications of humic substances have been explored for their potential benefits in promoting skin health and wound healing. Humic substances may exhibit anti-inflammatory, antimicrobial, and antioxidant properties that could help alleviate skin conditions such as eczema, acne, and dermatitis. Additionally, humic substances may support tissue repair and regeneration, speeding up the healing process of wounds and ulcers.
Anti-inflammatory Effects: Humic substances may exert anti-inflammatory effects by modulating inflammatory pathways and cytokine production. As inflammation plays a role in the pathogenesis of various chronic diseases, including arthritis, asthma, and inflammatory bowel disease, the anti-inflammatory properties of humic substances may have therapeutic potential in managing these conditions. However, more research is needed to elucidate the mechanisms of action and assess their clinical efficacy.
| Rank | Probiotic | Impact |
|---|---|---|
| species | Bacteroides uniformis | Reduces |
We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.
| π Direct Citations | πͺπΆ Indirect Citations | Taxonomy | Rank | Effect |
|---|---|---|---|---|
| 0 | 1 | Terrabacteria group | clade | Decreases |
| 0 | 1 | Clostridia | class | Decreases |
| 0 | 1 | Desulfuribacillia | class | Decreases |
| 0 | 1 | Dethiobacteria | class | Decreases |
| 0 | 1 | Limnochordia | class | Decreases |
| 0 | 1 | Thermolithobacteria | class | Decreases |
| 0 | 1 | Erysipelotrichia | class | Decreases |
| 0 | 1 | Tissierellia | class | Decreases |
| 0 | 1 | Negativicutes | class | Decreases |
| 0 | 1 | Bacilli | class | Decreases |
| 0 | 1 | Bacteroidaceae | family | Decreases |
| 0 | 1 | Selenomonadaceae | family | Decreases |
| 0 | 1 | Oscillospiraceae | family | Decreases |
| 0 | 1 | Comamonadaceae | family | Increases |
| 0 | 1 | Prevotellaceae | family | Increases |
| 1 | 0 | Anaerovibrio | genus | Decreases |
| 1 | 0 | Bacteroides | genus | Decreases |
| 1 | 0 | Oscillospira | genus | Decreases |
| 1 | 0 | Ruminococcus | genus | Decreases |
| 1 | 0 | Curvibacter | genus | Increases |
| 1 | 0 | Prevotella | genus | Increases |
| 0 | 1 | Bacillota incertae sedis | no rank | Decreases |
| 0 | 1 | Bacillota sensu stricto incertae sedis | no rank | Decreases |
| 0 | 1 | environmental samples | no rank | Decreases |
| 0 | 1 | environmental samples | no rank | Decreases |
| 0 | 1 | environmental samples | no rank | Decreases |
| 0 | 1 | environmental samples | no rank | Decreases |
| 0 | 1 | environmental samples | no rank | Decreases |
| 0 | 1 | unclassified Anaerovibrio | no rank | Decreases |
| 0 | 1 | unclassified Bacillota | no rank | Decreases |
| 0 | 1 | unclassified Bacteroides | no rank | Decreases |
| 0 | 1 | unclassified Oscillospira | no rank | Decreases |
| 0 | 1 | unclassified Ruminococcus | no rank | Decreases |
| 0 | 1 | environmental samples | no rank | Increases |
| 0 | 1 | unclassified Curvibacter | no rank | Increases |
| 0 | 1 | unclassified Prevotella | no rank | Increases |
| 1 | 0 | Bacillota | phylum | Decreases |
| 0 | 1 | Bacteroides togonis | QST454 | Decreases |
| 0 | 1 | Bacteroides bouchesdurhonensis | QSV445 | Decreases |
| 0 | 1 | Ruminococcus bicirculans (ex Wegman et al. 2014) | species | Decreases |
| 0 | 1 | Ruminococcus champanellensis | species | Decreases |
| 0 | 1 | Anaerovibrio lipolyticus | species | Decreases |
| 0 | 1 | Anaerovibrio slackiae | species | Decreases |
| 0 | 1 | Bacteroides acidifaciens | species | Decreases |
| 0 | 1 | Bacteroides caecigallinarum | species | Decreases |
| 0 | 1 | Bacteroides caecimuri | species | Decreases |
| 0 | 1 | Bacteroides chinchillae | species | Decreases |
| 0 | 1 | Bacteroides clarus | species | Decreases |
| 0 | 1 | Bacteroides congonensis | species | Decreases |
| 0 | 1 | Bacteroides cutis | species | Decreases |
| 0 | 1 | Bacteroides denticanum | species | Decreases |
| 0 | 1 | Bacteroides difficilis | species | Decreases |
| 0 | 1 | Bacteroides faecalis | species | Decreases |
| 0 | 1 | Bacteroides faecichinchillae | species | Decreases |
| 0 | 1 | Bacteroides finegoldii | species | Decreases |
| 0 | 1 | Bacteroides fluxus | species | Decreases |
| 0 | 1 | Bacteroides galacturonicus | species | Decreases |
| 0 | 1 | Bacteroides gallinaceum | species | Decreases |
| 0 | 1 | Bacteroides gallinarum | species | Decreases |
| 0 | 1 | Bacteroides graminisolvens | species | Decreases |
| 0 | 1 | Bacteroides ihuae | species | Decreases |
| 0 | 1 | Bacteroides ilei | species | Decreases |
| 0 | 1 | Bacteroides koreensis | species | Decreases |
| 0 | 1 | Bacteroides kribbi | species | Decreases |
| 0 | 1 | Bacteroides luti | species | Decreases |
| 0 | 1 | Bacteroides mediterraneensis | species | Decreases |
| 0 | 1 | Bacteroides muris (ex Fokt et al. 2023) | species | Decreases |
| 0 | 1 | Bacteroides ndongoniae | species | Decreases |
| 0 | 1 | Bacteroides oleiciplenus | species | Decreases |
| 0 | 1 | Bacteroides parvus | species | Decreases |
| 0 | 1 | Bacteroides propionicifaciens | species | Decreases |
| 0 | 1 | Bacteroides propionicigenes | species | Decreases |
| 0 | 1 | Bacteroides pyogenes | species | Decreases |
| 0 | 1 | Bacteroides reticulotermitis | species | Decreases |
| 0 | 1 | Bacteroides rhinocerotis | species | Decreases |
| 0 | 1 | Bacteroides rodentium | species | Decreases |
| 0 | 1 | Bacteroides sp | species | Decreases |
| 0 | 1 | Bacteroides sp. C13EG172 | species | Decreases |
| 0 | 1 | Bacteroides stercorirosoris | species | Decreases |
| 0 | 1 | Bacteroides timonensis | species | Decreases |
| 0 | 1 | Candidatus Bacteroides intestinigallinarum | species | Decreases |
| 0 | 1 | Oscillospira guilliermondii | species | Decreases |
| 0 | 1 | Ruminococcus bromii | species | Decreases |
| 0 | 1 | Ruminococcus callidus | species | Decreases |
| 0 | 1 | Ruminococcus difficilis | species | Decreases |
| 0 | 1 | Ruminococcus flavefaciens | species | Decreases |
| 0 | 1 | Ruminococcus hominis | species | Decreases |
| 0 | 1 | Ruminococcus intestinalis | species | Decreases |
| 0 | 1 | Ruminococcus turbiniformis | species | Decreases |
| 0 | 1 | Ruminococcus albus | species | Decreases |
| 0 | 1 | Bacteroides ovatus | species | Decreases |
| 0 | 1 | Bacteroides uniformis | species | Decreases |
| 0 | 1 | Bacteroides luhongzhouii | species | Decreases |
| 0 | 1 | Bacteroides fragilis | species | Decreases |
| 0 | 1 | Bacteroides xylanisolvens | species | Decreases |
| 0 | 1 | Ruminococcus bovis | species | Decreases |
| 0 | 1 | Bacteroides thetaiotaomicron | species | Decreases |
| 0 | 1 | Bacteroides caecimuris | species | Decreases |
| 0 | 1 | Bacteroides humanifaecis | species | Decreases |
| 0 | 1 | Bacteroides faecium | species | Decreases |
| 0 | 1 | Bacteroides salyersiae | species | Decreases |
| 0 | 1 | Bacteroides faecis | species | Decreases |
| 0 | 1 | Bacteroides helcogenes | species | Decreases |
| 0 | 1 | Bacteroides eggerthii | species | Decreases |
| 0 | 1 | Ruminococcus gauvreauii | species | Decreases |
| 0 | 1 | Bacteroides caccae | species | Decreases |
| 0 | 1 | Bacteroides intestinalis | species | Decreases |
| 0 | 1 | Bacteroides cellulosilyticus | species | Decreases |
| 0 | 1 | Bacteroides stercoris | species | Decreases |
| 0 | 1 | Bacteroides nordii | species | Decreases |
| 0 | 1 | Bacteroides zhangwenhongii | species | Decreases |
| 0 | 1 | Bacteroides heparinolyticus | species | Decreases |
| 0 | 1 | Bacteroides coprosuis | species | Decreases |
| 0 | 1 | Bacteroides zoogleoformans | species | Decreases |
| 0 | 1 | Prevotella fusca | species | Increases |
| 0 | 1 | Prevotella herbatica | species | Increases |
| 0 | 1 | Prevotella multiformis | species | Increases |
| 0 | 1 | Xylanibacter brevis | species | Increases |
| 0 | 1 | Prevotella micans | species | Increases |
| 0 | 1 | Xylanibacter ruminicola | species | Increases |
| 0 | 1 | Prevotella histicola | species | Increases |
| 0 | 1 | Prevotella amnii | species | Increases |
| 0 | 1 | Prevotella communis | species | Increases |
| 0 | 1 | Prevotella nigrescens | species | Increases |
| 0 | 1 | Prevotella scopos | species | Increases |
| 0 | 1 | Prevotella jejuni | species | Increases |
| 0 | 1 | Prevotella veroralis | species | Increases |
| 0 | 1 | Prevotella disiens | species | Increases |
| 0 | 1 | Prevotella melaninogenica | species | Increases |
| 0 | 1 | Prevotella corporis | species | Increases |
| 0 | 1 | Prevotella massiliensis | species | Increases |
| 0 | 1 | Prevotella denticola | species | Increases |
| 0 | 1 | Prevotella dentalis | species | Increases |
| 0 | 1 | Prevotella intermedia | species | Increases |
| 0 | 1 | Candidatus Prevotella avicola | species | Increases |
| 0 | 1 | Candidatus Prevotella stercoripullorum | species | Increases |
| 0 | 1 | Curvibacter gracilis | species | Increases |
| 0 | 1 | Curvibacter lanceolatus | species | Increases |
| 0 | 1 | Curvibacter putative symbiont of Hydra magnipapillata | species | Increases |
| 0 | 1 | Prevotella aurantiaca | species | Increases |
| 0 | 1 | Prevotella brunnea | species | Increases |
| 0 | 1 | Prevotella conceptionensis | species | Increases |
| 0 | 1 | Prevotella dentasini | species | Increases |
| 0 | 1 | Prevotella falsenii | species | Increases |
| 0 | 1 | Prevotella marseillensis | species | Increases |
| 0 | 1 | Prevotella merdae | species | Increases |
| 0 | 1 | Prevotella pallens | species | Increases |
| 0 | 1 | Prevotella pectinovora | species | Increases |
| 0 | 1 | Prevotella phocaeensis | species | Increases |
| 0 | 1 | Prevotella sp. P5-119 | species | Increases |
| 0 | 1 | Xylanibacter oryzae | species | Increases |
| 0 | 1 | Xylanibacter rarus | species | Increases |
| 0 | 1 | Prevotella bivia | species | Increases |
A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.
We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive X|increases + Y|decrease = Negative.
Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.
| Condition | Positive Impact | Negative Impact | Benefit Ratio Impact |
|---|---|---|---|
| Abdominal Aortic Aneurysm | 0.2 | 0.6 | -2 |
| Acne | 1.3 | 1 | 0.3 |
| ADHD | 2.6 | 1.6 | 0.63 |
| Age-Related Macular Degeneration and Glaucoma | 0.2 | -0.2 | |
| Allergic Rhinitis (Hay Fever) | 0.5 | 0.6 | -0.2 |
| Allergies | 2.9 | 3.1 | -0.07 |
| Allergy to milk products | 1.6 | 1.1 | 0.45 |
| Alopecia (Hair Loss) | 0.6 | 0.5 | 0.2 |
| Alzheimer's disease | 3.8 | 3.6 | 0.06 |
| Amyotrophic lateral sclerosis (ALS) Motor Neuron | 0.7 | 1.4 | -1 |
| Ankylosing spondylitis | 1.8 | 2.3 | -0.28 |
| Anorexia Nervosa | 0.5 | 1.7 | -2.4 |
| Antiphospholipid syndrome (APS) | 0.2 | 0.2 | |
| Asthma | 1.7 | 2.3 | -0.35 |
| Atherosclerosis | 1.2 | 1.3 | -0.08 |
| Atrial fibrillation | 1.8 | 1.1 | 0.64 |
| Autism | 4.2 | 2.7 | 0.56 |
| Autoimmune Disease | 0.6 | -0.6 | |
| benign prostatic hyperplasia | 0.7 | -0.7 | |
| Biofilm | 0.2 | -0.2 | |
| Bipolar Disorder | 2.1 | 2.1 | 0 |
| Brain Trauma | 1 | 1 | 0 |
| Breast Cancer | 0.5 | 0.5 | 0 |
| Cancer (General) | 0.5 | 0.7 | -0.4 |
| Carcinoma | 1 | 1.8 | -0.8 |
| Celiac Disease | 1.6 | 2.1 | -0.31 |
| Cerebral Palsy | 1.1 | 1.6 | -0.45 |
| Chronic Fatigue Syndrome | 2.7 | 2.1 | 0.29 |
| Chronic Kidney Disease | 1 | 1.1 | -0.1 |
| Chronic Lyme | 0.5 | -0.5 | |
| Chronic Obstructive Pulmonary Disease (COPD) | 1.3 | 0.8 | 0.63 |
| Chronic Urticaria (Hives) | 0.6 | 0.2 | 2 |
| Coagulation / Micro clot triggering bacteria | 0.5 | 0.5 | 0 |
| Cognitive Function | 1.8 | 0.5 | 2.6 |
| Colorectal Cancer | 3.8 | 3.1 | 0.23 |
| Constipation | 2.5 | 1.1 | 1.27 |
| Coronary artery disease | 1.1 | 1.4 | -0.27 |
| COVID-19 | 3.7 | 5.8 | -0.57 |
| Crohn's Disease | 2.1 | 3.7 | -0.76 |
| Cushing's Syndrome (hypercortisolism) | 0.5 | -0.5 | |
| cystic fibrosis | 0.9 | -0.9 | |
| deep vein thrombosis | 0.7 | 2 | -1.86 |
| Depression | 4 | 3.9 | 0.03 |
| Dermatomyositis | 0.5 | -0.5 | |
| Eczema | 0.3 | 0.2 | 0.5 |
| Endometriosis | 1.7 | 1.4 | 0.21 |
| Eosinophilic Esophagitis | 1.6 | -1.6 | |
| Epilepsy | 1.8 | 1.6 | 0.13 |
| erectile dysfunction | 0.5 | 0.3 | 0.67 |
| Fibromyalgia | 0.7 | 0.7 | 0 |
| Functional constipation / chronic idiopathic constipation | 3.9 | 2.6 | 0.5 |
| gallstone disease (gsd) | 1.2 | 1.2 | |
| Gastroesophageal reflux disease (Gerd) including Barrett's esophagus | 1.3 | 1.1 | 0.18 |
| Generalized anxiety disorder | 2.2 | 1.6 | 0.38 |
| Glioblastoma | 0.6 | 0.2 | 2 |
| Gout | 2 | 1.5 | 0.33 |
| Graves' disease | 1.2 | 3.3 | -1.75 |
| Gulf War Syndrome | 0.8 | 0.4 | 1 |
| Halitosis | 0.5 | 1.1 | -1.2 |
| Hashimoto's thyroiditis | 2 | 1.1 | 0.82 |
| Heart Failure | 2.1 | 1.6 | 0.31 |
| hemorrhagic stroke | 0.5 | -0.5 | |
| Hemorrhoidal disease, Hemorrhoids, Piles | 0.5 | 0.5 | |
| Hidradenitis Suppurativa | 0.5 | 1.1 | -1.2 |
| High Histamine/low DAO | 0.4 | 0.5 | -0.25 |
| hypercholesterolemia (High Cholesterol) | 0.5 | 0.6 | -0.2 |
| hyperglycemia | 0.7 | -0.7 | |
| Hyperlipidemia (High Blood Fats) | 0 | 0 | |
| hypersomnia | 0.6 | -0.6 | |
| hypertension (High Blood Pressure | 1.9 | 2.7 | -0.42 |
| Hypothyroidism | 0.7 | 1.1 | -0.57 |
| Hypoxia | 1.4 | 1.4 | |
| IgA nephropathy (IgAN) | 2.2 | 2 | 0.1 |
| Inflammatory Bowel Disease | 3 | 3.6 | -0.2 |
| Insomnia | 1.6 | 3.8 | -1.37 |
| Intelligence | 2.7 | 2.7 | |
| Intracranial aneurysms | 1.7 | 0.7 | 1.43 |
| Irritable Bowel Syndrome | 3.1 | 2.9 | 0.07 |
| ischemic stroke | 2.7 | 1.6 | 0.69 |
| Juvenile idiopathic arthritis | 0.5 | -0.5 | |
| Liver Cirrhosis | 1.8 | 2.1 | -0.17 |
| Long COVID | 2.2 | 3 | -0.36 |
| Low bone mineral density | 0.3 | -0.3 | |
| Lung Cancer | 0.1 | 1.2 | -11 |
| Lymphoma | 0 | 0 | |
| Mast Cell Issues / mastitis | 1.5 | 0.5 | 2 |
| ME/CFS with IBS | 0.5 | -0.5 | |
| ME/CFS without IBS | 0.5 | -0.5 | |
| membranous nephropathy | 0.6 | -0.6 | |
| Menopause | 0.2 | 0.9 | -3.5 |
| Metabolic Syndrome | 3.7 | 4.3 | -0.16 |
| Mood Disorders | 4.5 | 4.4 | 0.02 |
| Multiple Sclerosis | 1.8 | 2.3 | -0.28 |
| Multiple system atrophy (MSA) | 0.5 | -0.5 | |
| neuropathic pain | 0.5 | -0.5 | |
| Neuropathy (all types) | 0.5 | 0.5 | 0 |
| neuropsychiatric disorders (PANDAS, PANS) | 0.3 | 0.5 | -0.67 |
| Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic | 3.2 | 2.6 | 0.23 |
| NonCeliac Gluten Sensitivity | 1.2 | 1 | 0.2 |
| Obesity | 3.2 | 4.9 | -0.53 |
| obsessive-compulsive disorder | 3 | 1 | 2 |
| Osteoarthritis | 0.7 | 2.1 | -2 |
| Osteoporosis | 1.5 | 1.9 | -0.27 |
| pancreatic cancer | 0.8 | 1 | -0.25 |
| Parkinson's Disease | 3.7 | 4 | -0.08 |
| Polycystic ovary syndrome | 3.1 | 3.8 | -0.23 |
| primary biliary cholangitis | 1.2 | -1.2 | |
| Primary sclerosing cholangitis | 0.5 | 1 | -1 |
| Psoriasis | 1.9 | 1.1 | 0.73 |
| rheumatoid arthritis (RA),Spondyloarthritis (SpA) | 3 | 3 | 0 |
| Rosacea | 0.9 | 0.5 | 0.8 |
| Schizophrenia | 2.5 | 2.5 | 0 |
| scoliosis | 0.8 | 0.5 | 0.6 |
| Sjögren syndrome | 1.1 | 1.3 | -0.18 |
| Sleep Apnea | 1.2 | 1 | 0.2 |
| Slow gastric motility / Gastroparesis | 1.6 | 0.6 | 1.67 |
| Small Intestinal Bacterial Overgrowth (SIBO) | 0.7 | 1.1 | -0.57 |
| Stress / posttraumatic stress disorder | 0.5 | 1.6 | -2.2 |
| Systemic Lupus Erythematosus | 2 | 2.5 | -0.25 |
| Tic Disorder | 1.7 | 0.6 | 1.83 |
| Tourette syndrome | 0.7 | -0.7 | |
| Type 1 Diabetes | 3 | 2 | 0.5 |
| Type 2 Diabetes | 3.8 | 4.2 | -0.11 |
| Ulcerative colitis | 3 | 4.2 | -0.4 |
| Unhealthy Ageing | 1.3 | 1 | 0.3 |
| Vitiligo | 1.2 | 0.3 | 3 |
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served. Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license. Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models. Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]